Aurora Cannabis Inc.
NASDAQ:ACB
5.98 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 270.281 | 233.29 | 221.339 | 245.252 | 278.906 | 247.939 | 55.196 | 18.067 | 1.439 | 0 | 0 | 0 | 0 | 0 | 0 | 0.041 | 0 | 0 |
Cost of Revenue
| 138.821 | 297.65 | 200.114 | 266.81 | 312.445 | 88.124 | 11.677 | 2.011 | 0.763 | 0.305 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 131.46 | -64.36 | 21.225 | -21.558 | -33.539 | 159.815 | 43.519 | 16.056 | 0.676 | -0.305 | 0 | 0 | 0 | 0 | 0 | 0.041 | 0 | 0 |
Gross Profit Ratio
| 0.486 | -0.276 | 0.096 | -0.088 | -0.12 | 0.645 | 0.788 | 0.889 | 0.47 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
Reseach & Development Expenses
| 3.572 | 6.561 | 10.389 | 11.447 | 26.07 | 14.778 | 1.679 | 0.314 | 0.565 | 0.432 | 0.308 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 104.939 | 68.219 | 126.969 | 139.68 | 265.175 | 279.404 | 80.415 | 14.397 | 3.928 | 2.608 | 0.281 | 0.153 | 0.25 | 0.182 | 0.05 | 0.185 | 0 | 0 |
Selling & Marketing Expenses
| 51.937 | 51.967 | 62.025 | 55.198 | 91.271 | 99.289 | 29.445 | 10.27 | 1.706 | 1.022 | 0.248 | 0.143 | 0.061 | 0.019 | 0.007 | 0 | 0 | 0 |
SG&A
| 156.876 | 183.397 | 188.994 | 194.878 | 356.446 | 378.693 | 109.86 | 24.667 | 5.635 | 3.63 | 0.281 | 0.296 | 0.311 | 0.201 | 0.057 | 0.185 | 0.229 | 0.001 |
Other Expenses
| 1.669 | 0 | -21.588 | 6.133 | -28.643 | -3.263 | -0.907 | -1.135 | 0.593 | -5.061 | 0.026 | 0.107 | 0.019 | 0 | 0.001 | 0.001 | 0 | 0 |
Operating Expenses
| 158.539 | 189.958 | 240.6 | 225.087 | 450.93 | 456.842 | 123.627 | 25.697 | 6.793 | 4.367 | 0.306 | 0.403 | 0.331 | 0.201 | 0.058 | 0.186 | 0.229 | 0.001 |
Operating Income
| -46.453 | -254.318 | -231.449 | -282.818 | -490.962 | -314.244 | -95.772 | -11.192 | -4.591 | -4.367 | -0.306 | -0.403 | -0.331 | -0.202 | -0.058 | -0.145 | -0.229 | -0.001 |
Operating Income Ratio
| -0.172 | -1.09 | -1.046 | -1.153 | -1.76 | -1.267 | -1.735 | -0.619 | -3.19 | 0 | 0 | 0 | 0 | 0 | 0 | -3.56 | 0 | 0 |
Total Other Income Expenses Net
| -31.147 | -41.101 | -1,433.439 | -392.461 | -2,826.879 | 6.142 | 168.082 | -1.902 | 0.089 | -5.063 | -0.093 | 0.009 | 0.015 | -0.167 | 0 | 0 | 0 | 0 |
Income Before Tax
| -59.599 | -295.419 | -1,720.12 | -699.798 | -3,383.896 | -328.231 | 77.326 | -17.264 | -5.872 | -9.726 | -0.4 | -0.393 | -0.316 | -0.354 | 0 | 0 | 0 | 0 |
Income Before Tax Ratio
| -0.221 | -1.266 | -7.771 | -2.853 | -12.133 | -1.324 | 1.401 | -0.956 | -4.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| -0.554 | -20.316 | -2.141 | -6.321 | -83.403 | -30.307 | 8.1 | -4.296 | -0.149 | -0.208 | 0.008 | 0 | 0 | -0.031 | -0.014 | 0 | -0.052 | -0.001 |
Net Income
| -69.326 | -265.329 | -1,717.624 | -693.625 | -3,310.337 | -290.837 | 71.936 | -12.968 | -5.724 | -9.518 | -0.4 | -0.393 | -0.316 | -0.322 | -0.044 | -0.146 | -0.177 | 0.001 |
Net Income Ratio
| -0.256 | -1.137 | -7.76 | -2.828 | -11.869 | -1.173 | 1.303 | -0.718 | -3.977 | 0 | 0 | 0 | 0 | 0 | 0 | -3.567 | 0 | 0 |
EPS
| -1.46 | -8.22 | -7.99 | -41.01 | -342.14 | -435.59 | 1.88 | -0.56 | -0.53 | -1.48 | -0.3 | -0.29 | -0.24 | -0.24 | -0.036 | -0.12 | -0.19 | 0.008 |
EPS Diluted
| -1.46 | -8.22 | -7.99 | -41.01 | -342.14 | -435.59 | 1.83 | -0.56 | -0.53 | -1.48 | -0.3 | -0.29 | -0.24 | -0.24 | -0.036 | -0.12 | -0.19 | 0.008 |
EBITDA
| 20.474 | -210.745 | -143.089 | -137.2 | -393.231 | -214.662 | -78.456 | -12.983 | -4.749 | -9.242 | -0.298 | -0.402 | -0.33 | -0.185 | -0.057 | -0.145 | -0.229 | -0.001 |
EBITDA Ratio
| 0.076 | -0.903 | -0.646 | -0.559 | -1.41 | -0.866 | -1.421 | -0.719 | -3.3 | 0 | 0 | 0 | 0 | 0 | 0 | -3.539 | 0 | 0 |